| Zugriffe | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 460 |
| November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | Mai 2026 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 21 | 14 | 44 | 15 | 29 | 16 | 1 |
| Zugriffe | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 268 |
